Stonepine Capital Management, LLC, 10% Owner at Recro Pharma, Inc. (REPH), sold 510,000 shares at $7.40 ($3.8M) on 2017-05-12, disclosed to the SEC on 2017-05-15.
Open-market sale of $3.8M REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.40 | 73,930 | $547K | 14.5% |
| 2 | $7.40 | 436,070 | $3.2M | 85.5% |
| Total | $7.40 avg | 510,000 | $3.8M | 100% |
| Filing → |